Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Release of Interferon-β (IFN-β) from Probiotic Limosilactobacillus reuteri-IFN-β (LR-IFN-β) Mitigates Gastrointestinal Acute Radiation Syndrome (GI-ARS) following Whole Abdominal Irradiation.
Hamade DF, Epperly MW, Fisher R, Hou W, Shields D, van Pijkeren JP, Mukherjee A, Yu J, Leibowitz BJ, Vlad AM, Coffman L, Wang H, Huq MS, Huang Z, Rogers CJ, Greenberger JS. Hamade DF, et al. Among authors: coffman l. Cancers (Basel). 2023 Mar 8;15(6):1670. doi: 10.3390/cancers15061670. Cancers (Basel). 2023. PMID: 36980556 Free PMC article.
Lactobacillus reuteri Releasing IL-22 (LR-IL-22) Facilitates Intestinal Radioprotection for Whole-Abdomen Irradiation (WAI) of Ovarian Cancer.
Hamade DF, Espinal A, Yu J, Leibowitz BJ, Fisher R, Hou W, Shields D, van Pijkeren JP, Mukherjee A, Epperly MW, Vlad AM, Coffman L, Wang H, Saiful Huq M, Patel R, Huang J, Greenberger JS. Hamade DF, et al. Among authors: coffman l. Radiat Res. 2022 Jul 1;198(1):89-105. doi: 10.1667/RADE-21-00224.1. Radiat Res. 2022. PMID: 35446961 Free PMC article.
Intestinal Radiation Protection and Mitigation by Second-Generation Probiotic Lactobacillus-reuteri Engineered to Deliver Interleukin-22.
Espinal A, Epperly MW, Mukherjee A, Fisher R, Shields D, Wang H, Huq MS, Hamade DF, Vlad AM, Coffman L, Buckanovich R, Yu J, Leibowitz BJ, van Pijkeren JP, Patel RB, Stolz D, Watkins S, Ejaz A, Greenberger JS. Espinal A, et al. Among authors: coffman l. Int J Mol Sci. 2022 May 17;23(10):5616. doi: 10.3390/ijms23105616. Int J Mol Sci. 2022. PMID: 35628427 Free PMC article.
Genetically Engineered Probiotic Limosilactobacillus reuteri Releasing IL-22 (LR-IL-22) Modifies the Tumor Microenvironment, Enabling Irradiation in Ovarian Cancer.
Hamade DF, Epperly MW, Fisher R, Hou W, Shields D, van Pijkeren JP, Leibowitz BJ, Coffman LG, Wang H, Huq MS, Huang Z, Rogers CJ, Vlad AM, Greenberger JS, Mukherjee A. Hamade DF, et al. Among authors: coffman lg. Cancers (Basel). 2024 Jan 23;16(3):474. doi: 10.3390/cancers16030474. Cancers (Basel). 2024. PMID: 38339228 Free PMC article.
Phase I trial of ribociclib with platinum chemotherapy in ovarian cancer.
Coffman LG, Orellana TJ, Liu T, Frisbie LG, Normolle D, Griffith K, Uppal S, McLean K, Berger J, Boisen M, Courtney-Brooks M, Edwards RP, Lesnock J, Mahdi H, Olawaiye A, Sukumvanich P, Taylor SE, Buckanovich R. Coffman LG, et al. JCI Insight. 2022 Sep 22;7(18):e160573. doi: 10.1172/jci.insight.160573. JCI Insight. 2022. PMID: 35972817 Free PMC article. Clinical Trial.
The role of adjuvant treatment for early-stage uterine clear cell carcinomas.
Orellana TJ, Garrett AA, Soong TR, Rives T, Courtney-Brooks M, Taylor SE, Lesnock J, Berger J, Boisen M, Coffman L, Buckanovich R, Mahdi H, Comerci JC, Beriwal S, Sukumvanich P, Edwards RP, Bhargava R, Olawaiye AB. Orellana TJ, et al. Among authors: coffman l. Gynecol Oncol. 2023 Mar;170:77-83. doi: 10.1016/j.ygyno.2022.12.024. Epub 2023 Jan 13. Gynecol Oncol. 2023. PMID: 36641903
64 results